Rhabdomyosarcoma — Trials

Rhabdomyosarcoma — Trials · CancerIndex

Clinical trials

Registered studies

210 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 74
Recruiting: 37
Ph III recruiting: 4
Growth YoY: —
Industry share: 9%
Top sponsor: National Cancer Institute (NCI)
Termination share: 25%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (22)

clinicaltrialsPublishedShowing 1–1 of 1 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00162695	Rhabdomyosarcoma and Malignant Soft Tissue Tumours of Childhood	terminated	Phase 3	400	Gustave Roussy, Cancer Campus, Grand ParisOTHER	1	Sep 13, 2005	clinicaltrials

Data updated 22 days agoSource updated Sep 13, 2005source: clinicaltrials